Elevance Health Inc.

NYSE:ELV

Medical - Healthcare Plans

Healthcare
$400.84 -0.88%

-$3.45 today

Market cap
$86.60B
Beta
0.68
P/E (TTM)
16.3
EPS (TTM)
$23.78
Dividend yield
1.77%
52W Low $273.71High $426.98

Volume 1.91M

Average 1.68M

ELV Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Elevance Health Inc.NYSE: ELV

Accounts Payables · Q3 FY2026 · quarter ended Sep 2026

Accounts payables turns positive

Q3 FY2026 accounts payables was $1.24B, compared with -$151M a year earlier. Trailing-twelve-month accounts payables was -$1.02B.

Context

  • Accounts payables amounted to 0.4% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts payables holds near $1.24B or moves back toward the trailing-twelve-month quarterly average of -$254.75M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$1.24B+143.0% QoQ
Last fiscal yearDec 2025
-$720M+164.7% YoY
LTMSep 2026
-$1.02B-400.6% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+921.2%——
1 year+164.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
(720M) USD
Year-over-year change
-164.7%

Accounts Payables vs competitors

How ELV compares with its peers on the latest reported figures

  • ELV's LTM Sep 2026 accounts payables of $1.02B is the 4th largest of the 9 companies compared; the peer median is $68.24M.
  • Its year-over-year change of -400.6% is the lowest of 9, against a peer median of +4.6%.
  • Accounts payables amounts to 0.5% of revenue for ELV, versus a peer median of 0.4%.
ELV Competitors Peer median
Accounts Payables for ELV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CNCCentene CorporationLTM Jun 2026$6.37B +332.8%—3.3%
UNHUnitedHealth Group IncorporatedLTM Sep 2026$6.18B -183.6%—1.4%
CICigna CorporationLTM Sep 2026$3.55B +304.3%+17.3%1.2%
ELVElevance Health Inc.LTM Sep 2026$1.02B -400.6%—0.5%
CVSCVS Health CorporationLTM Jun 2026$947M -80.8%-3.3%0.2%
HUMHumana Inc.LTM Sep 2026$121M -88.3%—0.1%
OSCROscar Health, Inc.LTM Jun 2026$74.49M -60.0%-15.7%0.5%
MOHMolina Healthcare, Inc.LTM Sep 2026$62M +231.9%—0.1%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$6.26M +69.2%—0.1%
Peer median (excluding ELV) $68.24M+4.6%-3.3%0.4%

Competitors are the stored peer set for ELV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income6.1B6.02B5.99B5.97B5.66B
Depreciation & Amortization1.3B1.68B1.75B1.39B1.55B
Deferred Income Tax173M(76M)(602M)(374M)(279M)
Stock-Based Compensation255M264M289M191M276M
Change in Working Capital784M253M(535M)(1.72B)(3.28B)
Accounts Receivables(2.14B)(2.51B)(1.76B)(683M)(2.53B)
Inventory2.14B2.51B000
Accounts Payables719M252M1.64B(272M)(720M)
Other Working Capital65M1M(413M)(764M)(31M)
Other Non-Cash Items(245M)264M1.18B346M363M
Operating Cash Flow8.36B8.4B8.06B5.81B4.29B
Capital Expenditures(1.09B)(1.15B)(1.3B)(1.26B)(1.12B)
Acquisitions (Net)(3.48B)(649M)(1.55B)(4.45B)88M
Purchases of Investments(18.67B)(24.95B)(16.24B)(17.99B)(15.03B)
Sales of Investments14.61B22.61B13.54B18.57B15.1B
Other Investing Activities(1.02B)(421M)(24M)(51M)(385M)
Investing Cash Flow(9.64B)(4.56B)(5.57B)(5.17B)(1.34B)
Debt Repayment2.34B1.8B739M5.56B2.33B
Common Stock Issued00000
Common Stock Repurchased(1.9B)(2.32B)(2.68B)(2.9B)(2.61B)
Dividends Paid(1.1B)(1.23B)(1.4B)(1.51B)(1.53B)
Other Financing Activities1.08B432M(17M)39M69M
Financing Cash Flow423M(1.32B)(3.35B)1.19B(1.74B)
Effect of Forex Changes(10M)(14M)(1M)(72M)(5M)
Net Change in Cash(861M)2.51B(861M)1.76B1.2B
Free Cash Flow7.28B7.25B6.77B4.55B3.17B

Elevance Health Inc.

NYSE:ELV

Intrinsic Alpha fair value

Locked

Current Price

$400.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.